Multiple Sclerosis News Today is providing comprehensive and in-depth coverage of the eighth annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2023 in San Diego, California. The theme of this year’s conference is “MS: Going Viral.”
A portable MRI device may be used to detect brain lesions that are indicative of multiple sclerosis (MS), and serve as a low-cost imaging tool that can be brought to patients for testing, according to a new analysis.
Cognitive behavioral therapy (CBT), a form of talk therapy, and medication given separately or in combination can ease fatigue significantly for people with multiple sclerosis (MS), according to new data from a clinical trial. The effect on fatigue…
Evobrutinib, an experimental BTK inhibitor being developed for people with relapsing forms of multiple sclerosis (MS), continues to be well tolerated and is showing low relapse rates after four years of treatment. That’s according to new data…
The multiple sclerosis (MS) community is gearing up for the eighth annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum, taking place this week both virtually and in San Diego, California. The yearly meeting, occurring…
Senior science writer Marisa Horak, MS, and science writer Lindsey Shapiro, PhD, talk about how they came to Bionews and Multiple Sclerosis News Today, why conferences like ACTRIMS are important, and the highlights of this year’s forum.
Mitzi Joi Williams, MD, founding medical director of Joi Life Wellness, talks about the documentary “MS in Black and African Americans,” progress that has been made in addressing racial disparities in MS care and research, and what still needs to be done to close the gap.
MS advocate and patient Tyler Campbell discusses the documentary “MS in Black and African Americans,” his MS diagnosis journey, and the importance of taking action to address health inequities among the Black MS community.
Michael Hotchkin, chief development officer of Clene Nanomedicine, explains how experimental therapy CNM-Au8 may help MS patients see improvements in their everyday lives. Full story to come.
Michael Weiss, CEO of TG Therapeutics, talks to Multiple Sclerosis News Today about the pricing of newly approved MS therapy Briumvi (ublituximab) and how they are helping people with MS afford the treatment.
Multiple Sclerosis News Today talks to Mitzi Joi Williams, MD, MS specialist and founding medical director of Joi Life Wellness, about health inequity in Black people with MS and what further work needs to be done to close the gap. Full story and video to come.
MS patient and advocate Tyler Campbell sits down with Multiple Sclerosis News Today to talk about his MS experience and the documentary “MS in Black and African Americans,” which premiered Thursday night at ACTRIMS. Full story and video to come.
Can Do MS Chief Operating Officer Kathy Costello chats with Multiple Sclerosis News Today about the upcoming programs and initiatives they’re most excited about. Full story to come.
Get regular updates to your inbox.
